Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas

Abstract

Incorporating CGP into sarcoma management may allow for more precise diagnosis and sub-classification of this diverse and rare disease, as well as personalized matching of patients to targeted therapies such as those available in basket clinical trials.